Four insights:
1. The new Ortholoc 2 LapiFuse Triplanar Correction System is designed to increase fusion, reduce recurrence rates and lower the risk of metatarsalgia.
2. The system features a tarsometatarsal joint preparation kit, which is intended to help surgeons quickly and efficiently debride the joint.
3. The Ortholoc 2 LapiFuse system also addresses toe length preservation and facilitates reproducible triplanar correction.
4. It will become commercially available on April 3.
More articles on orthopedic devices:
Stryker ranks No. 8 in Fortune’s 100 best workplaces
10 numbers that show how big Johnson & Johnson is in spine, orthopedics
15 spine devices receive FDA 510(k) clearance in January
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
